BRITTANY TUBBS: Open Payments
NPI 1841018264 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 30 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 6 | $227 |
| Medtronic, Inc. | 3 | $152 |
| RGH Enterprises LLC | 3 | $146 |
| Corcept Therapeutics | 6 | $112 |
| Dexcom, Inc. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Lilly USA, LLC | 2 | $38 |
| Tandem Diabetes Care, Inc. | 2 | $31 |
| Ascensia Diabetes Care Us Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $23 |
Products named: TWIIST, MINIMED 780G, Korlym, Dexcom G6 Transmitter, FARXIGA, t:slim X2 Insulin Pump with Control-IQ, MOUNJARO, FREESTYLE LIBRE.
Industry payments across MS — which companies pay providers there.
